Literature DB >> 21355863

Underlying mechanisms of ovarian cancer risk reduction after tubal ligation.

David Cibula1, Martin Widschwendter, Michael Zikan, Ladislav Dusek.   

Abstract

A recently published meta-analysis of 21 studies confirmed a protective effect of tubal ligation on the risk of invasive ovarian cancer. This protective measure has received little attention, particularly due to the elusive underlying mechanism. In this commentary we discuss available data concerning the contribution of different potential mechanisms by which tubal ligation might prevent ovarian cancer. Included were studies published in English, identified through a literature search using PubMed and EMBASE. Four main mechanisms are discussed: (a) a screening effect, (b) alteration of ovarian function, (c) a mechanical barrier against ascending carcinogenic agents and (d) prevention of endometrial and proximal Fallopian tube cell ascent. There are arguments supporting the major role of a mechanical barrier to the ascent of endometrial cells into the peritoneal cavity for decreasing risk of ovarian cancer after tubal ligation. Prevention of retrograde transport of carcinogenic substances from the vagina may be an additional mechanism.
© 2011 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2011 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355863     DOI: 10.1111/j.1600-0412.2011.01114.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  15 in total

1.  Preventing ovarian cancer by salpingectomy.

Authors:  W D Foulkes
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

Review 2.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

3.  Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.

Authors:  Collette R Lessard-Anderson; Kathryn S Handlogten; Rochelle J Molitor; Sean C Dowdy; William A Cliby; Amy L Weaver; Jennifer St Sauver; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2014-10-12       Impact factor: 5.482

4.  Fallopian Tube Ligation or Salpingectomy as Means for Reducing Risk of Ovarian Cancer.

Authors:  J Brian Szender; Shashikant B Lele
Journal:  AMA J Ethics       Date:  2015-09-01

5.  Tubal ligation and ovarian cancer risk in African American women.

Authors:  Chrissy McNamara; Sarah E Abbott; Elisa V Bandera; Bo Qin; Lauren C Peres; Fabian Camacho; Patricia G Moorman; Anthony J Alberg; Jill S Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Joellen M Schildkraut; Paul Terry
Journal:  Cancer Causes Control       Date:  2017-09-04       Impact factor: 2.506

Review 6.  Update on permanent contraception options for women.

Authors:  Eva Patil; Jeffrey T Jensen
Journal:  Curr Opin Obstet Gynecol       Date:  2015-12       Impact factor: 1.927

7.  Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria.

Authors:  Ekaterina Tiourin; Victor S Velasco; Miguel A Rosales; Peggy S Sullivan; Deanna M Janzen; Sanaz Memarzadeh
Journal:  Reprod Sci       Date:  2015-03-02       Impact factor: 3.060

8.  The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.

Authors:  Amy L Shafrir; Megan S Rice; Mamta Gupta; Kathryn L Terry; Bernard A Rosner; Rulla M Tamimi; Jonathan L Hecht; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2016-10-05       Impact factor: 5.482

9.  Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.

Authors:  Joanne Kotsopoulos; Kathryn L Terry; Elizabeth M Poole; Bernard Rosner; Megan A Murphy; Jonathan L Hecht; Christopher P Crum; Stacey A Missmer; Daniel W Cramer; Shelley S Tworoger
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396

10.  Evolution, ovulation and cancer.

Authors:  K Vijayraghavan; Satyajit Rath
Journal:  Elife       Date:  2013-04-16       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.